AD8 Application icon

AD8 3.0.6

4.4 MB / 1+ Downloads / Rating 5.0 - 1 reviews


See previous versions

AD8, developed and published by Washington University in St. Louis, has released its latest version, 3.0.6, on 2024-11-02. This app falls under the Education category on the Google Play Store and has achieved over 50 installs. It currently holds an overall rating of 5.0, based on 1 reviews.

AD8 APK available on this page is compatible with all Android devices that meet the required specifications (Android 5.0+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.appcatalyst.ad8

Updated: 3 months ago

Developer Name: Washington University in St. Louis

Category: Education

New features: Show more

App Permissions: Show more

Installation Instructions

This article outlines two straightforward methods for installing AD8 on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

Previous Versions

AD8 3.0.6
2024-11-02 / 4.4 MB / Android 5.0+

About this app

The AD8 is an 8-question interview tool which distinguishes individuals with very mild dementia from those without dementia, regardless of etiology.  Questions are given to the respondent for self–administration or can be read aloud to the respondent either in person or over the phone. It is preferable to administer the AD8 to an informant, if available. If an informant is not available, the AD8 may be administered to the patient. Administration guidelines along with information on interpreting the results are contained within the app.

Screening tests such as the AD8 are insufficient to diagnose a dementing disorder. The AD8 is, however, sensitive to detecting early cognitive changes associated with many common dementing illnesses, including Alzheimer disease, vascular dementia, Lewy body dementia, and frontotemporal dementia. The AD8 is based on intra-individual decline and has been demonstrated to be a valid and reliable screening tool for dementia.

You assume all liability due to or arising from your use of the AD8. Washington University will not be liable to Licensee for any loss, claim or demand made or incurred by the Licensee or any third party, due to or arising from the use of the AD8 by Licensee. Before using the AD8 app, all users will be required to read and accept the full Permission & Licensing Statement displayed when the app opens.

New features

*Updated target API level

App Permissions

Allows applications to open network sockets.
Allows applications to access information about networks.
Allows using PowerManager WakeLocks to keep processor from sleeping or screen from dimming.